NCT01964183

Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine

Post-Marketing Study of Mirabegron - A Pharmacokinetic Study to Assess Drug-Drug Interaction Between Mirabegron and Tolterodine -

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: Female
• Age: 45 Years – 70 Years
• Healthy volunteers: Accepted

Summary

To assess the effect of multiple doses of mirabegron to postmenopausal adult female subjects on the pharmacokinetics (PK) of tolterodine and its metabolites. In addition, the safety of these products will be assessed.

Conditions

• Pharmacokinetics of Mirabegron and Tolterodine
• Healthy

Interventions

Type	Name	Description
DRUG	tolterodine	Oral
DRUG	mirabegron	Oral

Timeline

• Start date: 2013-06-01
• Primary completion: 2013-08-01
• Completion: 2013-08-01
• First posted: 2013-10-17
• Last updated: 2013-10-17

Locations

1 site across 1 country: Japan